宫颈癌中EphA2，nm23-H1蛋白的表达与淋巴结转移的相关性研究

doi:10.3760/cma.j.issn.1673-5250.2008.04.104

目的

检测EphA2蛋白和nm23-H1蛋白在宫颈癌中的表达，探讨其与淋巴结转移的关系。

方法

本研究标本取自2002年3月至2005年12月在川北医学院附属医院妇产科手术切除的56例宫颈癌石蜡标本(实验组)，采用免疫组化S-P法检测EphA2,nm23-H1蛋白在56例宫颈癌(12例有淋巴结转移，44例无淋巴结转移)患者石蜡标本和在12例正常宫颈组织标本(对照组)中的表达，分析EphA2和nm23-H1蛋白的表达与淋巴结转移的关系。

结果

本研究结果显示，EphA2蛋白实验组的阳性表达率(85.7%,48/56)明显高于对照组(25.0%,3/12)。实验组中，12例有淋巴结转移患者的EphA2蛋白的阳性率为100%，44例不伴随淋巴结转移患者EphA2蛋白的阳性率为81.8%(36/44)，两者比较，差异有显著意义(P<0.05)。实验组nm23-H1蛋白的阳性表达率(48. 2%,27/56)低于对照组(91.7%,11/12)。实验组中，12例有淋巴结转移患者的nm23-H1蛋白阳性表达率为8.3%(1/12)，44例不伴有淋巴结转移患者的为59.1%(26/44)，两者比较，差异有显著意义(P<0. 01)。

结论

EphA2和nm23-H1蛋白在宫颈癌中的表达与患者有无淋巴结转移密切相关。这提示，EphA2和nm23-H1蛋白可望为宫颈癌患者预后，提供参考依据。

关键词: EphA2蛋白, nm23-H1蛋白, 淋巴结转移, 宫颈癌

Objective

To investigate the expression of EphA2 protein and nm23-H1 protein in cervical cancer and their relationship with lymph node metastasis.

Methods

56 patients with cervical cancer(from March 2002 to December 2005, in the Department of Gynecology and Obstetrics, the Affiliated Hospital of North Sichuan Medical University)were enrolled in this study, including 12 cases with lymph node metastasis and 44 cases without lymph node metastasis. The expression of EphA2 protein and nm23-H1 protein in 56 cases of cervical cancer and 12 cases of normal cervical tissue(the control group)were detected by immunohistochemistry S-P method.

Results

The positive expression rate of EphA2 protein in 56 cases of cervical cancer(85. 7%,48/56)was significantly higher than that of the control group(25.0%,3/12)(P<0.01), and the positive rate of EphA2 in 12 cases with lymph node metastasis(100%)was higher than that in cases without lymph node metastasis(81.8%,36/44)(P<0. 05). The positive expression rate of nm23-H1 protein in cervical cancer(48.2%,27/56)was significantly lower than that in the control group(91.7%,11/12)(P<0.01), and the positive rate of nm23-H1 in 12 cases with lymph node metastasis(8.3%, 1/12)was lower than that in those without lymph node metastasis(59.1%,26/44)(P<0.01).

Conclusion

The expression of EphA2 protein is positively related to lymph node metastasis and nm23-H1 protein is negatively related to metastasis in cervical cancer, which may serve as a reference for the prognosis in cervical cancer.

Key words: EphA2 protein, nm23-H1 protein, lymph node metastasis, cervical cancer

图1　EphA2在宫颈癌中的阳性表达

图2　EphA2蛋白的表达与宫颈癌伴随淋巴结转移的关系

图3　nm23-H1在宫颈癌中的阳性表达

	1 Walker-Daniels J, Hess AR, Hendrix MJ, et al. Differential regulation of EphA2 in normal and malignant cells. Am J Pathol, 2003, 162(4):1037-1042.
	2 Fang WB, Brantley-Sieders DM, Parker MA, et al. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis. Oncogene, 2005, 24(53): 7859-7868.
	3 Wu D, Suo Z, Kristensen GB, et al. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gyneol Oncol, 2004, 94(2): 312-319.
	4 Thaker PH, Deavers M, Celestino J, et al. EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res,2004, 10(15):5145-5150.
	5 Easty DJ, Hill SP, Hsu MY, et al. Up-regulation of ephrin-Al during melanoma progression. Int J Cancer, 1999, 84(5): 494-501.
	6 Hess AR, Seftor EA, Gardner LM, et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase(Eck/EphA2). Cancer Res, 2001, 61(8): 3250-3255.
	7 Kataoka H, Igarashi H, Kanamori M, et al. Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer. Cancer Sci, 2004, 95(2): 136-141.
	8 Brantley-Sieders DM, Fang WB, Hicks DJ, et al. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. FASEB J,2005, 19(13): 1884-1886.
	9 Ni XH, Gu SH, Dai IL, et al. Isolation and characterization of a novel human B gene A different transcription of nm23Hl.J Hum Genet, 2003,4(8):96.
	10 Hartsough MT, Morrison DK, Salerno M,et al. Nm23-Hl metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.J Biol Chem, 2002, 277(35): 32389-32399.
	11 Zhou ZP, Liu SM, Liu HQ. The expression and clinical significances of p53, nm23 proteins in squamous cell carcinoma of the uterine cervix. Acta Academiae Med Zunyi, 2004,27(2): 131.[周正平，刘世梅，刘华庆．P53,nm23蛋白在宫颈鳞癌中的表达及其临床意义．遵义医学院学报，2004,27(2)：131.]

[1]	孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(07): 734-742.
[2]	陈启阳, 刘玉江, 刘金苹, 谭小蕖, 钱林学, 胡向东. 基于超声造影的预测模型对甲状腺乳头状癌颈中央区淋巴结转移的诊断价值[J]. 中华医学超声杂志（电子版）, 2023, 20(04): 442-448.
[3]	李素娟, 丁文波, 武心萍, 邓学东. 被膜侵犯的甲状腺微小乳头状癌发生颈部淋巴结转移的超声相关危险因素分析[J]. 中华医学超声杂志（电子版）, 2023, 20(04): 455-461.
[4]	崔亭亭, 李俨育, 王茜, 傅晓凤, 范公林, 高力, 谢磊, 章德广, 朱江. 细针穿刺洗脱液甲状腺球蛋白诊断甲状腺乳头状癌颈部淋巴结转移的阈值及效能分析[J]. 中华医学超声杂志（电子版）, 2023, 20(02): 219-226.
[5]	刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[6]	孙笑非, 顾依群, 王爱春, 王荔, 孟凡凡, 王军, 卢利娟. 细胞块p16/Ki-67双染对子宫颈炎患者宫颈上皮内瘤变的诊断价值[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(06): 418-425.
[7]	李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[8]	樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[9]	李永浩, 高雪菲, 郭田田, 张进, 刘静. 峡部甲状腺乳头状癌手术方式的研究现状[J]. 中华普通外科学文献(电子版), 2023, 17(03): 225-230.
[10]	徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[11]	袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAF^V600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[12]	单兴利, 王栋, 邢念增, 肖泽均, 李亚健. ⁶⁸Ga-PSMA-PET/CT对前列腺癌盆腔淋巴结转移诊断价值的研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 214-218.
[13]	钱小卫, 丁海兵, 游继军, 王熠, 卞小霞. 微小miR水平联合检测在非小细胞肺癌转移中的意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 47-50.
[14]	王莹莹, 王卡娜, 陈思敬, 王娜, 郑莹. 腹腔镜宫颈广泛切除术治疗特殊类型宫颈黏液性癌[J]. 中华腔镜外科杂志(电子版), 2022, 15(06): 372-375.
[15]	周灿坤, 李庆东, 江卓飞, 肇丽杰, 郑玉华, 柳晓春, 谢庆煌, 黄晓斌. 阴式广泛联合经阴道内镜腹膜外淋巴结切除术[J]. 中华腔镜外科杂志(电子版), 2022, 15(06): 368-371.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Expression of EphA2 Protein and nm23-H1 Protein in Cervical Cancer Associated With Lymph Node Metastasis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Expression of EphA2 Protein and nm23-H1 Protein in Cervical Cancer Associated With Lymph Node Metastasis